Companies: 10,795·Total market cap: $144.5T
PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation

PRCTNASDAQHealthcare● Active
$28.66
+$0.83(+2.98%)
Market Cap$1.6B
P/E Ratio
52W High$66.85
52W Low$19.35

PROCEPT BioRobotics Corporation (PRCT) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

PRCT · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$286.5M -14.1% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$286.5M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-14.1%
vs prior fiscal year
Latest Quarter
$245.6M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$286.5MCash on Hand
Total Debt$51.6MTotal Debt
Net Cash / Net Debt+$234.9MNet Cash Position
Cash vs Debt Ratio
Cash 85%Debt 15%

PROCEPT BioRobotics Corporation has a net cash position of $234.9M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$286.5M$51.6M = +$234.9M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
PRCT annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$286.5M-14.1%
Dec 31, 2024$333.7M+29.7%
Dec 31, 2023$257.2M+15.5%
Dec 31, 2022$222.6M-26.8%
Dec 31, 2021$304.3M+203.9%
PRCT cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
PROCEPT BioRobotics Corporation
PROCEPT BioRobotics CorporationYOU
PRCT
$286.5M17.6%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

PROCEPT BioRobotics Corporation (PRCT) cash on hand as of December 31, 2025 is $286.5M, comprising $286.5M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as PROCEPT BioRobotics Corporation cash and short-term investments on the balance sheet (10-K filing). Also referred to as PROCEPT BioRobotics Corporation cash reserves or cash position.

PROCEPT BioRobotics Corporation annual cash on hand history shows decreased -14.1% in 2025: decreased -14.1% in 2025. PROCEPT BioRobotics Corporation cash reserves in 2025 reflect the company's capital allocation strategy.

PROCEPT BioRobotics Corporation carries total debt of $51.6M against cash of $286.5M, resulting in a net cash position of +$234.9M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

PRCT cash on hand · 5 questions

As of December 31, 2025, PROCEPT BioRobotics Corporation (PRCT) has $286,503,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $286,503,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $245,641,000. Data sourced from the annual 10-K filing via FMP.

PRCT cash on handPRCT cash reservesPRCT cash 2025how much cash does PRCT have

Source: FMP /balance-sheet-statement · US GAAP · PROCEPT BioRobotics Corporation · PROCEPT BioRobotics Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025